Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Weight Loss

Recent news which mentions Weight Loss

< Previous 1 2 3 4 5 6 7 Next >

Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update

June 23, 2025

Novo Nordisk's Weight Loss Injection CagriSema Data Sparks Investor Concern

June 23, 2025

Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns

June 23, 2025

Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere

June 20, 2025

Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study

June 18, 2025

Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499

June 16, 2025

Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock

June 13, 2025

Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company

June 13, 2025

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice

June 11, 2025

Eli Lilly Inks Pact With Juvena Therapeutics To Develop Muscle-Boosting Drugs

June 11, 2025

Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies

June 11, 2025

Metsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss Data

June 09, 2025

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy

June 09, 2025

Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say

June 06, 2025

Hims & Hers ZAVA Acquisition Deal Expands Its Market Opportunity By $52 Billion: Analyst

June 04, 2025

Mounjaro Maker Eli Lilly Taps Swedish Firm Camurus To Target Long-Acting Obesity Market In $870-Million Deal

June 04, 2025

Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge

June 03, 2025

Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target

June 02, 2025

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025

Eli Lilly's May Meltdown Is In History Books — Could June Seasonality Bring A Rebound?

May 27, 2025

Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds

May 14, 2025

Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs

May 14, 2025

Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook

May 07, 2025

Novo Nordisk's Weight Loss Blockbuster Faces Setback From US Compounding Surge, Forecast Trimmed

May 07, 2025

CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment

May 01, 2025

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

April 29, 2025

Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform

April 29, 2025

Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy

April 25, 2025

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence

April 22, 2025

Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars

April 17, 2025

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.